UPDATE: Thursday broker round-up

27th Oct 2011 09:09

Smith&Nephew: Citi reiterates sell.Anglo American: Citi maintains at buy.Invensys: UBS raises to neutral-short term buy from neutral. Lowers target to 225p from 250p. Bellway: UBS keeps at buy, raises target price to 825p from 793p.Lloyds: Credit Suisse cuts target to 31p from 40p, keeps at neutral. Glaxo Smith Kline: Credit Suisse keeps at neutral.Glaxo Smith Kline: RBS stays at buy and keeps target at 17.25p.Informa: Alpha Value lowers to add from buy, target at 463.4p from 463.7p.Kazakhmys: Evolution Securities slashes target from 1,590p to 1,260p, keeps add rating.AstraZeneca: Bernstein repeats market perform recommendation.Royal Dutch Shell: Investec leaves hold rating and 2,250p unchanged.Aquarius Platinum: Evolution Securities cuts target from 312p to 225p, reiterates ("unenthusiastic") add recommendation.William Hill: Investec reiterates buy stance and 300p target.William Hill: Evolution Securities maintains buy rating and 285p target.Mitchells & Butlers: Evolution Securities keeps buy rating and 360p target.Inchcape: Investec keeps buy recommendation and target of 480p.DS Smith: Evolution Securities keeps buy rating and 350p target.DS Smith: Investec maintains buy rating and 320p target.RDS: Evolution Securities keeps buy rating and 2,500p target.Go-Ahead: Investec keeps buy stance, target of 1,670p unchanged.Bloomsbury Publishing: Investec maintains buy rating and 173p target.Brammar: Investec reiterates buy call and 375p target.Kewill: Investec reduces target from 122p to 93p, buy rating maintained.